- Business Wire•4 days agoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Momenta Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm
Goldberg Law PC announces that it is investigating Momenta Pharmaceuticals, Inc. concerning possible violations of federal securities laws.
- Business Wire•4 days agoGlancy Prongay & Murray LLP Commences Investigation on Behalf of Momenta Pharmaceuticals, Inc. Investors
Glancy Prongay & Murray LLP announces an investigation on behalf of Momenta Pharmaceuticals, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.
- Motley Fool•4 days ago
The attempted approval of the three-times-weekly version of Glatopa dominated the earnings conference call.
MNTA : Summary for Momenta Pharmaceuticals, Inc. - Yahoo Finance
Momenta Pharmaceuticals, Inc. (MNTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||15.50 x 400|
|Ask||15.80 x 600|
|Day's Range||15.15 - 15.98|
|52 Week Range||7.86 - 19.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-11.87|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|